Textbook of clinical trials: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
{{MultiCol}}
=== '''Ethical Issues''' ===
=== '''Ethical Issues''' ===


Line 9: Line 10:
==== [[HIPAA|HIPAA reidentification of patients and patient privacy]] ====
==== [[HIPAA|HIPAA reidentification of patients and patient privacy]] ====


{{ColBreak}}




Line 20: Line 22:


==== [[510(k)|510K pathway]] ====
==== [[510(k)|510K pathway]] ====
{{ColBreak}}


===  '''Designing Clinical Trials''' ===
===  '''Designing Clinical Trials''' ===
Line 50: Line 54:
==== [[Protocols|Protocol creation]] ====
==== [[Protocols|Protocol creation]] ====
[[Abbreviations used in clinical trials]]
[[Abbreviations used in clinical trials]]
{{ColBreak}}


===  '''Operationalizing Clinical Trials''' ===
===  '''Operationalizing Clinical Trials''' ===
Line 114: Line 120:


==== Publication committee ====
==== Publication committee ====
{{ColBreak}}


===  '''Statistical Analysis of Clinical Trials''' ===
===  '''Statistical Analysis of Clinical Trials''' ===
Line 150: Line 158:


==== Positive publication bias ====
==== Positive publication bias ====
{{ColBreak}}


===  '''Study Tools''' ===
===  '''Study Tools''' ===

Revision as of 20:07, 24 October 2019

Ethical Issues

Helsinki agreement

Informed consent

Investigational Review Board (IRB)

HIPAA reidentification of patients and patient privacy


Operationalizing Clinical Trials

Principal investigator role

Executive committee role

Steering committee role

Nurse coordinator clinical research associate role

Monitor role

Randomization service

Central laboratory facility

EKG core laboratory

Angiographic core laboratory

MRI core laboratory

Genetics core laboratory

Biomarker core laboratory

Identification of sites

Randomization

Blinding

Recruitment of study participants

Electronic data collection

Schedule of events

Concomitant medications

Clinical event committee or event adjudication committee

Adverse events, serious adverse events and serious unexpected events

Data safety monitoring board (DSMB)

Study drug discontinuation, withdrawal of consent, incomplete follow up and lost to follow up patients

Protocol adherence

Storage and handling of investigational product

Data management and designing an electronic data capture form

Source documents

Study completion and close out

Protocol amendments

Publication committee

Statistical Analysis of Clinical Trials

Cleaning a dataset

Summary statistics

Intent to treat versus modified intent to treat versus as treated

Student's t tests and analysis of variance

Chi square analysis and Fisher's exact test

Logistic regression

Multivariate modeling

Survival analysis

Handling missing data

Subgroup and interaction analyses

Net clinical benefit analyses

Cost effectiveness analyses

Quality adjusted life year analyses

Interim analyses and futility analyses

Reporting results and how to write a manuscript

Meta-analysis

Positive publication bias